From financialisation to innovation in UK big pharma: AstraZeneca and GlaxoSmithKline
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, United Kingdom
Cambridge University Press
2022
|
| Schriftenreihe: | Cambridge elements. Elements in reinventing capitalism
|
| Schlagworte: | |
| Online-Zugang: | 20.500.12854/142969 Volltext Volltext |
| Beschreibung: | 1 Online-Ressource (104 Seiten) Diagramme |
| ISBN: | 9781009278140 |
| DOI: | 10.1017/9781009278140 |
Internformat
MARC
| LEADER | 00000nmm a22000001c 4500 | ||
|---|---|---|---|
| 001 | BV048652297 | ||
| 003 | DE-604 | ||
| 005 | 20240917 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230116s2022 |||| o||u| ||||||eng d | ||
| 020 | |a 9781009278140 |c Online |9 978-1-009-27814-0 | ||
| 024 | 7 | |a 10.1017/9781009278140 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781009278140 | ||
| 035 | |a (OCoLC)1362877374 | ||
| 035 | |a (DE-599)BVBBV048652297 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-210 |a DE-521 |a DE-1102 |a DE-1046 |a DE-1028 |a DE-1050 |a DE-573 |a DE-M347 |a DE-92 |a DE-1051 |a DE-898 |a DE-859 |a DE-860 |a DE-1049 |a DE-863 |a DE-862 |a DE-Re13 |a DE-Y3 |a DE-255 |a DE-Y7 |a DE-Y2 |a DE-70 |a DE-2174 |a DE-127 |a DE-22 |a DE-155 |a DE-91 |a DE-384 |a DE-473 |a DE-19 |a DE-355 |a DE-703 |a DE-20 |a DE-706 |a DE-824 |a DE-945 |a DE-29 |a DE-739 | ||
| 100 | 1 | |a Tulum, Öner |d ca. 20./21. Jh. |e Verfasser |0 (DE-588)1279010541 |4 aut | |
| 245 | 1 | 0 | |a From financialisation to innovation in UK big pharma |b AstraZeneca and GlaxoSmithKline |c Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network) |
| 264 | 1 | |a Cambridge, United Kingdom |b Cambridge University Press |c 2022 | |
| 300 | |a 1 Online-Ressource (104 Seiten) |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cambridge elements. Elements in reinventing capitalism | |
| 653 | 2 | |a AstraZeneca (Firm) / Finance | |
| 653 | 2 | |a GlaxoSmithKline / Finance | |
| 653 | 0 | |a Pharmaceutical industry / Finance / Great Britain | |
| 653 | 0 | |a Biotechnology industry / Finance / Great Britain | |
| 700 | 1 | |a Andreoni, Antonio |e Verfasser |0 (DE-588)1019224118 |4 aut | |
| 700 | 1 | |a Lazonick, William |e Verfasser |0 (DE-588)17006090X |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-1-009-27816-4 |
| 856 | |u 20.500.12854/142969 | ||
| 856 | 4 | 0 | |u https://doi.org/10.1017/9781009278140 |x Verlag |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/142969 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ZDB-20-CBO |a ZDB-20-CUOA |a ZDB-94-OAB | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-034027060 | |
Datensatz im Suchindex
| DE-BY-FWS_katkey | 1029323 |
|---|---|
| _version_ | 1813306266469007360 |
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William |
| author_GND | (DE-588)1279010541 (DE-588)1019224118 (DE-588)17006090X |
| author_facet | Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William |
| author_role | aut aut aut |
| author_sort | Tulum, Öner ca. 20./21. Jh |
| author_variant | ö t öt a a aa w l wl |
| building | Verbundindex |
| bvnumber | BV048652297 |
| collection | ZDB-20-CBO ZDB-20-CUOA ZDB-94-OAB |
| ctrlnum | (ZDB-20-CBO)CR9781009278140 (OCoLC)1362877374 (DE-599)BVBBV048652297 |
| dewey-full | 338.7/616151/0941 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.7/616151/0941 |
| dewey-search | 338.7/616151/0941 |
| dewey-sort | 3338.7 6616151 3941 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| discipline_str_mv | Wirtschaftswissenschaften |
| doi_str_mv | 10.1017/9781009278140 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a22000001c 4500</leader><controlfield tag="001">BV048652297</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240917</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230116s2022 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009278140</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-009-27814-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009278140</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009278140</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1362877374</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048652297</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-521</subfield><subfield code="a">DE-1102</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-1028</subfield><subfield code="a">DE-1050</subfield><subfield code="a">DE-573</subfield><subfield code="a">DE-M347</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-1051</subfield><subfield code="a">DE-898</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-1049</subfield><subfield code="a">DE-863</subfield><subfield code="a">DE-862</subfield><subfield code="a">DE-Re13</subfield><subfield code="a">DE-Y3</subfield><subfield code="a">DE-255</subfield><subfield code="a">DE-Y7</subfield><subfield code="a">DE-Y2</subfield><subfield code="a">DE-70</subfield><subfield code="a">DE-2174</subfield><subfield code="a">DE-127</subfield><subfield code="a">DE-22</subfield><subfield code="a">DE-155</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-384</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-706</subfield><subfield code="a">DE-824</subfield><subfield code="a">DE-945</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-739</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tulum, Öner</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1279010541</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">From financialisation to innovation in UK big pharma</subfield><subfield code="b">AstraZeneca and GlaxoSmithKline</subfield><subfield code="c">Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, United Kingdom</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (104 Seiten)</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge elements. Elements in reinventing capitalism</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">AstraZeneca (Firm) / Finance</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">GlaxoSmithKline / Finance</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry / Finance / Great Britain</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biotechnology industry / Finance / Great Britain</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andreoni, Antonio</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1019224118</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lazonick, William</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)17006090X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-1-009-27816-4</subfield></datafield><datafield tag="856" ind1=" " ind2=" "><subfield code="u">20.500.12854/142969</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009278140</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://directory.doabooks.org/handle/20.500.12854/142969</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield><subfield code="a">ZDB-20-CUOA</subfield><subfield code="a">ZDB-94-OAB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034027060</subfield></datafield></record></collection> |
| id | DE-604.BV048652297 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:20:05Z |
| indexdate | 2024-10-19T04:06:53Z |
| institution | BVB |
| isbn | 9781009278140 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034027060 |
| oclc_num | 1362877374 |
| open_access_boolean | 1 |
| owner | DE-12 DE-210 DE-521 DE-1102 DE-1046 DE-1028 DE-1050 DE-573 DE-M347 DE-92 DE-1051 DE-898 DE-BY-UBR DE-859 DE-860 DE-1049 DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-Re13 DE-BY-UBR DE-Y3 DE-255 DE-Y7 DE-Y2 DE-70 DE-2174 DE-127 DE-22 DE-BY-UBG DE-155 DE-BY-UBR DE-91 DE-BY-TUM DE-384 DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-945 DE-29 DE-739 |
| owner_facet | DE-12 DE-210 DE-521 DE-1102 DE-1046 DE-1028 DE-1050 DE-573 DE-M347 DE-92 DE-1051 DE-898 DE-BY-UBR DE-859 DE-860 DE-1049 DE-863 DE-BY-FWS DE-862 DE-BY-FWS DE-Re13 DE-BY-UBR DE-Y3 DE-255 DE-Y7 DE-Y2 DE-70 DE-2174 DE-127 DE-22 DE-BY-UBG DE-155 DE-BY-UBR DE-91 DE-BY-TUM DE-384 DE-473 DE-BY-UBG DE-19 DE-BY-UBM DE-355 DE-BY-UBR DE-703 DE-20 DE-706 DE-824 DE-945 DE-29 DE-739 |
| physical | 1 Online-Ressource (104 Seiten) Diagramme |
| psigel | ZDB-20-CBO ZDB-20-CUOA ZDB-94-OAB |
| publishDate | 2022 |
| publishDateSearch | 2022 |
| publishDateSort | 2022 |
| publisher | Cambridge University Press |
| record_format | marc |
| series2 | Cambridge elements. Elements in reinventing capitalism |
| spellingShingle | Tulum, Öner ca. 20./21. Jh Andreoni, Antonio Lazonick, William From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline |
| title | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline |
| title_auth | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline |
| title_exact_search | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline |
| title_exact_search_txtP | From financialisation to innovation in UK Big Pharma AstraZeneca and GlaxoSmithKline |
| title_full | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network) |
| title_fullStr | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network) |
| title_full_unstemmed | From financialisation to innovation in UK big pharma AstraZeneca and GlaxoSmithKline Öner Tulum (The Academic-Industry Research Network), Antonio Andreoni (SOAS University of London), William Lazonick (The Academic-Industry Research Network) |
| title_short | From financialisation to innovation in UK big pharma |
| title_sort | from financialisation to innovation in uk big pharma astrazeneca and glaxosmithkline |
| title_sub | AstraZeneca and GlaxoSmithKline |
| url | 20.500.12854/142969 https://doi.org/10.1017/9781009278140 https://directory.doabooks.org/handle/20.500.12854/142969 |
| work_keys_str_mv | AT tulumoner fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline AT andreoniantonio fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline AT lazonickwilliam fromfinancialisationtoinnovationinukbigpharmaastrazenecaandglaxosmithkline |